Cannabinoids for chronic pain
Identifieur interne : 001430 ( Istex/Corpus ); précédent : 001429; suivant : 001431Cannabinoids for chronic pain
Auteurs : Steven P. CohenSource :
- BMJ [ 0959-8138 ] ; 2008-01-26.
Abstract
Is effective but research is needed to decide which subgroups of people benefit most
Url:
DOI: 10.1136/bmj.39434.444583.80
Links to Exploration step
ISTEX:E3EE0CD8EED18140C711C4A5462FE7E301E3C84CLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Cannabinoids for chronic pain</title><author wicri:is="90%"><name sortKey="Cohen, Steven P" sort="Cohen, Steven P" uniqKey="Cohen S" first="Steven P" last="Cohen">Steven P. Cohen</name><affiliation><mods:affiliation>1Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E3EE0CD8EED18140C711C4A5462FE7E301E3C84C</idno><date when="2008" year="2008">2008</date><idno type="doi">10.1136/bmj.39434.444583.80</idno><idno type="url">https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001430</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Cannabinoids for chronic pain</title><author wicri:is="90%"><name sortKey="Cohen, Steven P" sort="Cohen, Steven P" uniqKey="Cohen S" first="Steven P" last="Cohen">Steven P. Cohen</name><affiliation><mods:affiliation>1Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="ISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2008-01-26">2008-01-26</date><biblScope unit="volume">336</biblScope><biblScope unit="issue">7637</biblScope><biblScope unit="page" from="167">167</biblScope></imprint><idno type="ISSN">0959-8138</idno></series><idno type="istex">E3EE0CD8EED18140C711C4A5462FE7E301E3C84C</idno><idno type="DOI">10.1136/bmj.39434.444583.80</idno><idno type="href">bmj-336-167.pdf</idno><idno type="ArticleID">cohs2611</idno><idno type="PMID">18182415</idno><idno type="Related-article-href">10.1136/bmj.39429.619653.80</idno><idno type="local">bmj;336/7637/167</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0959-8138</idno></seriesStmt></fileDesc><profileDesc><textClass></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Is effective but research is needed to decide which subgroups of people benefit most</div></front></TEI><istex><corpusName>bmj</corpusName><author><json:item><name>Steven P Cohen</name><affiliations><json:string>1Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Clinical trials (epidemiology)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Immunology (including allergy)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Drugs: CNS (not psychiatric)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Multiple sclerosis</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Pain (neurology)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Pain (palliative care)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Pain (anaesthesia)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Psychotic disorders (incl schizophrenia)</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Somatoform disorders</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Drugs: musculoskeletal and joint diseases</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Health education</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Health promotion</value></json:item></subject><articleId><json:string>cohs2611</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>editorial</json:string></originalGenre><abstract>Is effective but research is needed to decide which subgroups of people benefit most</abstract><qualityIndicators><score>5.668</score><pdfVersion>1.4</pdfVersion><pdfPageSize>595.276 x 793.701 pts</pdfPageSize><refBibsNative>false</refBibsNative><keywordCount>12</keywordCount><abstractCharCount>84</abstractCharCount><pdfWordCount>5112</pdfWordCount><pdfCharCount>33162</pdfCharCount><pdfPageCount>6</pdfPageCount><abstractWordCount>14</abstractWordCount></qualityIndicators><title>Cannabinoids for chronic pain</title><pmid><json:string>18182415</json:string></pmid><genre><json:string>editorial</json:string></genre><host><volume>336</volume><publisherId><json:string>bmj</json:string></publisherId><pages><first>167</first></pages><issn><json:string>0959-8138</json:string></issn><issue>7637</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1468-5833</json:string></eissn><title>BMJ</title></host><publicationDate>2008</publicationDate><copyrightDate>2008</copyrightDate><doi><json:string>10.1136/bmj.39434.444583.80</json:string></doi><id>E3EE0CD8EED18140C711C4A5462FE7E301E3C84C</id><score>0.22854319</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Cannabinoids for chronic pain</title><respStmt><resp>Références bibliographiques récupérées via GROBID</resp><name resp="ISTEX-API">ISTEX-API (INIST-CNRS)</name></respStmt></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>British Medical Journal Publishing Group</publisher><availability><p>© BMJ Publishing Group Ltd 2008</p></availability><date>2008-01-08</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Cannabinoids for chronic pain</title><author xml:id="author-1"><persName><forename type="first">Steven P</forename><surname>Cohen</surname></persName><note type="biography">associate professor of anaesthesiology</note><affiliation>associate professor of anaesthesiology</affiliation><affiliation>1Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</affiliation></author></analytic><monogr><title level="j">BMJ</title><title level="j" type="abbrev">BMJ</title><idno type="pISSN">0959-8138</idno><idno type="eISSN">1468-5833</idno><imprint><publisher>British Medical Journal Publishing Group</publisher><date type="published" when="2008-01-26"></date><biblScope unit="volume">336</biblScope><biblScope unit="issue">7637</biblScope><biblScope unit="page" from="167">167</biblScope></imprint></monogr><idno type="istex">E3EE0CD8EED18140C711C4A5462FE7E301E3C84C</idno><idno type="DOI">10.1136/bmj.39434.444583.80</idno><idno type="href">bmj-336-167.pdf</idno><idno type="ArticleID">cohs2611</idno><idno type="PMID">18182415</idno><idno type="Related-article-href">10.1136/bmj.39429.619653.80</idno><idno type="local">bmj;336/7637/167</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2008-01-08</date></creation><langUsage><language ident="en">en</language></langUsage><abstract style="teaser"><p>Is effective but research is needed to decide which subgroups of people benefit most</p></abstract><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Clinical trials (epidemiology)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Immunology (including allergy)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Drugs: CNS (not psychiatric)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Multiple sclerosis</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Pain (neurology)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Pain (palliative care)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Pain (anaesthesia)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Psychotic disorders (incl schizophrenia)</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Somatoform disorders</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Drugs: musculoskeletal and joint diseases</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Health education</term></item></list></keywords></textClass><textClass><keywords scheme="keyword"><list><head>hwp-journal-coll</head><item><term>Health promotion</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2008-01-08">Created</change><change when="2008-01-26">Published</change><change xml:id="refBibs-istex" who="#ISTEX-API" when="2016-10-4">References added</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="corpus bmj" wicri:toSee="no header"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="no"</istex:xmlDeclaration><istex:docType PUBLIC="-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" URI="archivearticle.dtd" name="istex:docType"></istex:docType><istex:document><article article-type="editorial"><front><journal-meta><journal-id journal-id-type="hwp">bmj</journal-id><journal-id journal-id-type="nlm-ta">BMJ</journal-id><journal-id journal-id-type="publisher-id">bmj</journal-id><journal-title>BMJ</journal-title><abbrev-journal-title abbrev-type="publisher">BMJ</abbrev-journal-title><issn pub-type="ppub">0959-8138</issn><issn pub-type="epub">1468-5833</issn><publisher><publisher-name>British Medical Journal Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">cohs2611</article-id><article-id pub-id-type="doi">10.1136/bmj.39434.444583.80</article-id><article-id pub-id-type="other">bmj;336/7637/167</article-id><article-id pub-id-type="other">bmj;bmj.39434.444583.80</article-id><article-id pub-id-type="pmid">18182415</article-id><article-id pub-id-type="other">167</article-id><article-id pub-id-type="other">bmj.39434.444583.80</article-id><article-categories><subj-group subj-group-type="heading"><subject content-type="original">Editorials</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Clinical trials (epidemiology)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Immunology (including allergy)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Drugs: CNS (not psychiatric)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Multiple sclerosis</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Pain (neurology)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Pain (palliative care)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Pain (anaesthesia)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Psychotic disorders (incl schizophrenia)</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Somatoform disorders</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Drugs: musculoskeletal and joint diseases</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Health education</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>Health promotion</subject></subj-group></article-categories><title-group><article-title>Cannabinoids for chronic pain</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="no"><name><surname>Cohen</surname><given-names>Steven P</given-names></name><role>associate professor of anaesthesiology</role></contrib><aff id="aff1"><label>1</label>Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</aff><aff id="aff2"><label>2</label>Department of Surgery, Walter Reed Army Medical Center, Washington, DC 21205, USA</aff></contrib-group><author-notes><corresp><email>scohen40@jhmi.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>26</day><month>01</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>8</day><month>1</month><year>2008</year></pub-date><volume>336</volume><volume-id pub-id-type="other">336</volume-id><volume-id pub-id-type="other">336</volume-id><issue>7637</issue><issue-id pub-id-type="other">bmj;336/7637</issue-id><issue-id pub-id-type="other">7637</issue-id><issue-id pub-id-type="other">336/7637</issue-id><fpage>167</fpage><permissions><copyright-statement>© BMJ Publishing Group Ltd 2008</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>BMJ Publishing Group Ltd</copyright-holder></permissions><self-uri content-type="pdf" xlink:role="full-text" xlink:href="bmj-336-167.pdf"></self-uri><related-article xlink:href="10.1136/bmj.39429.619653.80" related-article-type="commentary-article" ext-link-type="doi" xlink:type="simple">Research, doi: 10.1136/bmj.39429.619653.80</related-article><abstract abstract-type="teaser"><p>Is effective but research is needed to decide which subgroups of people benefit most</p></abstract></article-meta></front></article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Cannabinoids for chronic pain</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Cannabinoids for chronic pain</title></titleInfo><name type="personal"><namePart type="given">Steven P</namePart><namePart type="family">Cohen</namePart><affiliation>1Pain Management Division, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA</affiliation><description>associate professor of anaesthesiology</description></name><typeOfResource>text</typeOfResource><genre type="editorial" displayLabel="editorial"></genre><subject><genre>hwp-journal-coll</genre><topic>Clinical trials (epidemiology)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Immunology (including allergy)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Drugs: CNS (not psychiatric)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Multiple sclerosis</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Pain (neurology)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Pain (palliative care)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Pain (anaesthesia)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Psychotic disorders (incl schizophrenia)</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Somatoform disorders</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Drugs: musculoskeletal and joint diseases</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Health education</topic></subject><subject><genre>hwp-journal-coll</genre><topic>Health promotion</topic></subject><originInfo><publisher>British Medical Journal Publishing Group</publisher><dateIssued encoding="w3cdtf">2008-01-26</dateIssued><dateCreated encoding="w3cdtf">2008-01-08</dateCreated><copyrightDate encoding="w3cdtf">2008</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract type="teaser">Is effective but research is needed to decide which subgroups of people benefit most</abstract><relatedItem type="host"><titleInfo><title>BMJ</title></titleInfo><titleInfo type="abbreviated"><title>BMJ</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">0959-8138</identifier><identifier type="eISSN">1468-5833</identifier><identifier type="PublisherID">bmj</identifier><identifier type="PublisherID-hwp">bmj</identifier><identifier type="PublisherID-nlm-ta">BMJ</identifier><part><date>2008</date><detail type="volume"><caption>vol.</caption><number>336</number></detail><detail type="issue"><caption>no.</caption><number>7637</number></detail><extent unit="pages"><start>167</start></extent></part></relatedItem><relatedItem type="reviewOf"><identifier type="doi">10.1136/bmj.39429.619653.80</identifier></relatedItem><identifier type="istex">E3EE0CD8EED18140C711C4A5462FE7E301E3C84C</identifier><identifier type="DOI">10.1136/bmj.39434.444583.80</identifier><identifier type="href">bmj-336-167.pdf</identifier><identifier type="ArticleID">cohs2611</identifier><identifier type="PMID">18182415</identifier><identifier type="Related-article-href">10.1136/bmj.39429.619653.80</identifier><identifier type="local">bmj;336/7637/167</identifier><accessCondition type="use and reproduction" contentType="copyright">© BMJ Publishing Group Ltd 2008</accessCondition><recordInfo><recordContentSource>BMJ</recordContentSource><recordOrigin>BMJ Publishing Group Ltd</recordOrigin></recordInfo></mods></metadata><enrichments><json:item><type>multicat</type><uri>https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/enrichments/multicat</uri></json:item><json:item><type>refBibs</type><uri>https://api.istex.fr/document/E3EE0CD8EED18140C711C4A5462FE7E301E3C84C/enrichments/refBibs</uri></json:item></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Belgique/explor/OpenAccessBelV2/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001430 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001430 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Belgique
|area= OpenAccessBelV2
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:E3EE0CD8EED18140C711C4A5462FE7E301E3C84C
|texte= Cannabinoids for chronic pain
}}
| This area was generated with Dilib version V0.6.25. |  |